AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Drops 89.5%

AB Corporate Bond ETF (NASDAQ:EYEG) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totaling 109 shares, a drop of 89.5% from the August 31st total of 1,040 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 461 shares, the short-interest ratio is presently 0.2 days.

AB Corporate Bond ETF Trading Down 0.3%

NASDAQ:EYEG traded down $0.12 during trading hours on Thursday, hitting $33.70. 316 shares of the stock were exchanged, compared to its average volume of 301. The company has a market capitalization of $26.96 million, a P/E ratio of -20.06 and a beta of 0.18. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $34.45 and its two-hundred day moving average is $34.95. AB Corporate Bond ETF has a twelve month low of $33.64 and a twelve month high of $36.63.

AB Corporate Bond ETF Cuts Dividend

The company also recently declared a monthly dividend, which was paid on Friday, September 4th. Stockholders of record on Tuesday, September 1st were paid a dividend of $0.1284 per share. This represents a $1.54 annualized dividend and a dividend yield of 4.6%. This is a drop from AB Corporate Bond ETF’s previous monthly dividend of $0.1427. The ex-dividend date of this dividend was Tuesday, September 1st. AB Corporate Bond ETF’s payout ratio is currently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.